Paxil Class Action Moves on in Canada as Lawsuits Still Filed in U.S.

GlaxoSmithKline, maker of the selective serotonin reuptake inhibitor Paxil, is mired in a class action lawsuit in Canada that alleges the antidepressant caused birth defects in children whose expectant mothers took the drug without the corporation’s adequate warning of the heightened risks. A British Columbia judge permitted the class action.

Psychiatry Panelists with Ties to Drug Industry Urge Antidepressants for Grief

In what some prominent critics have called a bonanza for the drug companies, the American Psychiatric Association this month voted to drop the old warning against diagnosing depression in the bereaved, opening the way for more of them to be diagnosed with major depression — and thus, treated with antidepressants. The change in the handbook, which could have significant financial implications for the $10 billion U.S. antidepressant market, was developed in large part by people affiliated with the pharmaceutical industry, an examination of financial disclosures shows.

Prescription Drugs Often Behind Mass Shootings

It is no secret that prescription drugs, notably antidepressants, can make psychiatric patients worse, not better and even precipitate violence. SSRI antidepressants like Prozac, Zoloft and Paxil are so linked to violence, they were given the FDA’s highest warning in 2004, a black box, for the suicidal risks they can create in young adults.

Ron Paul Tribute to CCHR Co-Founder, Dr. Thomas Szasz—Congressional Record

Mr. PAUL. Mr. Speaker, I ask unanimous consent to insert into the CONGRESSIONAL RECORD ‘‘The Man versus the Therapeutic State,’’ by Jacob Sullivan of Reason magazine. This piece pays tribute to Dr. Thomas Szasz, who passed away on September 8th of this year. Dr. Szasz, a trained psychiatrist, was the leading opponent of what he labeled the ‘‘therapeutic state.’’ For over fifty years, in 35 books, and hundreds of articles, Dr. Szasz defended human liberty and dignity against modern psychiatry.